Trial Profile
Clinical Trials Insight: 700011677
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2007
Price :
$35
*
At a glance
- Drugs Adipiplon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Neurogen Corporation
- 14 Jun 2007 Results reported at SLEEP 2007 meeting.
- 23 May 2007 Results presented at APA 2007.
- 01 Feb 2006 New trial record.